Rektales HIV-Mibkrobizid: Phase-1-Doppelblindstudie mit gutet Akzeptanz und Sicherheit von Tenofovir-1%-Gel (MTN-007) http://t.co/1qEGKrwTzO

Unprotected Receptive #AnalSex - Glycerin Tenofovir 1% Gel Safe Rectally → to Phase 2 Study http://t.co/nbiSPoDu9Q Ht @PittHealthSci

Unprotected Receptive #AnalSex - Glycerin Tenofovir 1% Gel Safe Rectally → to Phase 2 Study http://t.co/5BTx42JbuC Ht @PittHealthSci

A Phase 1 Randomized, Double Blind, Placebo Controlled Rectal Safety and Acceptability Study of #Tenofovir 1% gel http://t.co/anmyTN1I01

Unprotected Receptive #AnalSex - Glycerin Tenofovir 1% Gel Safe Rectally → to Phase 2 Study http://t.co/9Y7y0AHw9C Ht @PittHealthSci

#Rectal gel safe, acceptable 4 preventing #HIV from #anal sex in early phase clinical trial via PLOS... http://t.co/FcL3HXs6zt

Phase 1 Rectal Safety and Acceptability Study of Tenofovir 1% Gel http://t.co/H51LqVaD7F @PLOSONE @RectalMicro #HIV #microbicides

#Rectal gel safe, acceptable 4 preventing #HIV from #anal sex in early phase clinical trial via PLOS... http://t.co/FcL3HXs6zt

Phase 1 Rectal Safety and Acceptability Study of Tenofovir 1% Gel http://t.co/H51LqVaD7F @PLOSONE @RectalMicro #HIV #microbicides